Praxis precision medicines to host prax-628 program update

Presentation will be held virtually on tuesday, march 26, 2024 at 8:00 a.m. et praxis leadership will be joined by key opinion leader in epilepsy dr. daniel friedman, professor of neurology at nyu grossman school of medicine boston, march 25, 2024 (globe newswire) -- praxis precision medicines , inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will host a virtual program update to discuss its prax-628 program in epilepsy on tuesday, march 26, 2024 at 8:00 a.m.
PRAX Ratings Summary
PRAX Quant Ranking